# A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis

> **NCT00730145** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 8 (actual)

## Conditions studied

- Renal Dialysis
- Pharmacokinetics

## Interventions

- **DRUG:** PD-0332334

## Key facts

- **NCT ID:** NCT00730145
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2010-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00730145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00730145, "A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00730145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*